peptide elongation factor 2 has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnihotri, S; Ahern, CA; Barokas, A; Bowden, M; Bridon, G; Collins, VP; Delattre, O; Derry, WB; Dubuc, A; El-Naggar, A; Faubert, B; Galpin, JD; Gleave, ME; Hielscher, T; Jan, E; Jones, RG; Kool, M; Korshunov, A; Kwok, B; Leprivier, G; Li, A; Mateo, AR; Mathers, J; McCabe, MG; Northcott, PA; Pfister, SM; Pollak, M; Proud, CG; Remke, M; Rotblat, B; Smith, S; Somasekharan, SP; Sorensen, PH; Taylor, MD; Thomas, R; Tognon, CE; Wang, Y; Wu, X; Yu, B | 1 |
1 other study(ies) available for peptide elongation factor 2 and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.
Topics: AMP-Activated Protein Kinases; Animals; Brain Neoplasms; Caenorhabditis elegans; Cell Survival; Cell Transformation, Neoplastic; Elongation Factor 2 Kinase; Food Deprivation; Glioblastoma; HeLa Cells; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; NIH 3T3 Cells; Peptide Chain Elongation, Translational; Peptide Elongation Factor 2; Signal Transduction; Transplantation, Heterologous | 2013 |